Navigation Links
Brazil Opts for Indian Drugs Bypassing Merck

Brazilian President Luiz Inacio Lula da Silva has allowed his country to ignore US pharmaceutical giant Merck's patent on AIDS drug Efavirenz and opted for a cheaper generic alternative from India.

With a decree he signed Friday, Brazil will be able to import generic versions of Efavirenz from three companies in India - and the price for the drugs will be 72 percent lower than the price charged by Merck.

The Brazilian ministry of health had been negotiating with Merck for three years to bring down the Efavirenz price.

Lula had criticized Merck for charging higher prices to Brazil than to other countries, an attitude he regarded as "disrespectful".

According to the ministry, Merck charges Brazil $1.59 per capsule but Thailand pays only 64 cents.

Merck initially proposed a 2 percent reduction in the Efavirenz price, which the Brazilians rejected.

On April 25, the Brazilian government classified the drug as one "of public interest" and asked Merck to present another proposal within seven days.

Merck offered a 30 percent price cut but the Brazilian authorities still considered it unsatisfactory because it was possible to buy the generic version of the medicine for as low as $0.45.

Minister of Health Jose Gomes Temporao then advised President Lula to sign the decree establishing the "compulsory license" for the anti-HIV drug allowing Brazil to import the drug at lower prices from other overseas suppliers or even produce it locally.

Health authorities expect the new measure to save up to $30 million in 2007, as 75,000 of the 200,000 AIDS patients whose treatment is funded by the government are expected to use Efavirenz by the end of the year.

'"/>




Page: 1

Related medicine news :

1. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
2. Brazilian Women to Be Vaccinated To Prevent Uterine Cancer
3. Malaria and TB Kills Indian Kids in Brazil
4. 13,000 Cases of Dengue Found in Brazil in January
5. Down Syndrome Dolls in Brazil After Child Actors Success
6. Brazil’s Claim to Fame - Fat Women and Drunk Men, Survey Find
7. Brazilian Boost for Bird Flu Vaccines
8. Brazil Will Purchase Merck’s Antiretroviral If Price Not Lowere
9. Brazil Spider Offers Hope for Those Suffering from Erectile Dysfunction
10. Brazil Government In Contention With Merck Over Anti-AIDS Drug
11. Brazil Government In Contention With Merck Over Anti-AIDS Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/17/2017)... VA (PRWEB) , ... February 17, 2017 , ... ... the Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 ... , Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? , ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... ... February 17, 2017 , ... MAP ... today that Karen Pilley has been promoted to Chief Executive Officer. , ... healthcare paradigm – a shift that demands the transition from pay-for-service to pay-for-performance ...
(Date:2/17/2017)... ... 17, 2017 , ... PrideStaff, a national staffing organization, is ... Staffing Industry Analysts' 2017 "Staffing 100 North America" list. , Now in ... to the staffing industry over the last twelve months. Industry insiders and observers ...
(Date:2/17/2017)... ... ... Like most hospitals across the nation, Onslow Memorial Hospital is looking for ... Reduction Program (HRRP), the return of a patient to the hospital within 30 days ... many providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital has ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017  Noble ... coverage on ESSA Pharma Inc. (Nasdaq: EPIX ... Biotechnology Research, Kumar Raja , PhD. ... treatments for castration resistant prostate cancer (CRPC). Its lead ... selectively blocks the amino-terminal domain of the androgen receptor, ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... , Feb. 16, 2017  Aralez Pharmaceuticals Inc. ... specialty pharmaceutical company, today announced that executive management will ... to be held February 22-23, 2017. Adrian Adams ... the Company at 1:35 p.m. local time on Wednesday, ... audio archive for the event may be accessed from ...
Breaking Medicine Technology: